BridgeBio Pharma Inc (BBIO)
26.50
+0.28
(+1.09%)
USD |
NASDAQ |
Dec 20, 16:00
26.49
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Shareholders Equity (Quarterly): -1.230B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc | 92.29B |
| Alnylam Pharmaceuticals Inc | 32.35M |
| Cassava Sciences Inc | 166.64M |
| Regeneron Pharmaceuticals Inc | 29.33B |
| Vertex Pharmaceuticals Inc | 15.63B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 664.98M |
| Total Liabilities (Quarterly) | 1.883B |
| Debt to Equity Ratio | -1.398 |
| Current Ratio | 3.193 |
| Net Debt Paydown Yield | -0.00% |